Global Syringe Pump Market

𝐆𝐥𝐨𝐛𝐚𝐥 𝐬𝐲𝐫𝐢𝐧𝐠𝐞 𝐩𝐮𝐦𝐩 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟔.𝟔𝟐% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃𝟑𝟎𝟒𝟒𝟎.𝟎𝟐 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟕. Syring pumps are used for the in-vivo diagnosis, treatment and research purposes. Increasing prevalence of chronic diseases such as cardiovascular diseases, neurological disorders, among others are elevating the demand for syringe pump market. There are various benefits associated with syringe pumps that are driving the growth of the global syringe pumps market, which majorly includes the ability to gain effective symptom control due to steady plasma drug concentration without peaks and troughs, single route of administration that minimizes the need for repeated injections or multiple oral medicines. These syringe pumps allow the management of multiple symptoms by using a combination of medications given via a single route. Subcutaneous administration of medicine is far more comfortable than intramuscular injections and is simpler and less invasive. Based on the type, market can be segmented into infusion pump and drug pump. In 2021, infusion pump accounted for the share of 83.60% and the segment is expected to witness cotinued growth due to its widespread application in hospitals & clinics, ambulatory care settings, among others for delivering various fluids to the patients. Some of the players operating in the syringe pump market include Baxter International Inc., Medtronic Plc, ICU Medical,Inc., Becton, Dickinson and Company, Fresenius SE & Co. KGaA, Moog Inc. Syring pump market is fragmented with Baxter International Inc. accounting for the largest share in 2021.